Search by Drug Name or NDC

NDC 68788-8171-03 terazosin 2 mg/1 Details

terazosin 2 mg/1

terazosin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is TERAZOSIN HYDROCHLORIDE.

MedlinePlus Drug Summary

Terazosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. It also is used alone or in combination with other medications to treat high blood pressure. Terazosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate. It lowers blood pressure by relaxing the blood vessels so that blood can flow more easily through the body. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 68788-8171-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Terazosin

Product Information

NDC	68788-8171
Product ID	68788-8171_462d6fa8-b4c5-44cc-a2fd-ad7eb7b9ddcb
Associated GPIs	36202040100110
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	terazosin
Proprietary Name Suffix	n/a
Non-Proprietary Name	terazosin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	2
Active Ingredient Units	mg/1
Substance Name	TERAZOSIN HYDROCHLORIDE
Labeler Name	Preferred Pharmaceuticals Inc.
Pharmaceutical Class	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA075614
Listing Certified Through	2024-12-31

Package

NDC 68788-8171-03 (68788817103)

Pricing Information	N/A
NDC Package Code	68788-8171-3
Billing NDC	68788817103
Package	30 CAPSULE in 1 BOTTLE (68788-8171-3)
Marketing Start Date	2022-04-25
NDC Exclude Flag	N